CRISPR Therapeutics AG (CRSP) Minority Interest (2015 - 2016)
CRISPR Therapeutics AG (CRSP) reported Minority Interest of -$51000.0 for Q3 2016, down 88.89% sequentially from -$27000.0 in Q4 2015.
CRISPR Therapeutics AG (CRSP) Minority Interest (2015 - 2016) Analysis & Trends
CRISPR Therapeutics AG (CRSP) has 2 years of Minority Interest data on file, last reported at -$51000.0 in Q3 2016.
- For the quarter ending Q3 2016, Minority Interest changed N/A year-over-year to -$51000.0; the trailing twelve-month figure through Sep 2016 stood at -$51000.0 (changed N/A YoY), and the FY2015 full-year result was -$27000.0, changed N/A from the prior year.
- Minority Interest eased to -$51000.0 in Q3 2016, from -$27000.0 in the prior quarter.
- In the past five years, Minority Interest ranged from a high of -$27000.0 in Q4 2015 to a low of -$51000.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CRISPR Therapeutics AG | 4.57 Bn | 2.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | -51,000.00 |
| Dec 31, 2015 | -27,000.00 |